Cancer is the leading cause of disease-related death in children in most developed countries, and at least a quarter of these patients are diagnosed with aggressive high-risk or relapsed cancers, with an expected five-year survival rate of less than 30%.
Precision medicine doubles progression-free survival in young cancer patients
- Post author:
- Post published:June 2, 2024
- Post category:uncategorized